ISSN: 1699-3993

Drugs of Today Q3 Unclaimed

Prous Science Spain

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drugs of Today is a peer-reviewed journal with a solid reputation of over 40 years in the scientific publications market. It is a valuable source of information on drugs introduced into the international market. Its updated monographs and articles keep the medical community abreast of the latest developments in diagnosis and treatment across therapeutic areas It has an SJR impact factor of 0,427.

Type: Journal

Type of Copyright: -

Languages: English

Open Access Policy: Non Open Access

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q3) Pharmacology (Q3) Pharmacology (medical) (Q3) Pharmacology (medical) (Q3)

Price

- €

Inmediate OA

- €

Embargoed OA

0 €

Non OA

Metrics

0,427

SJR Impact factor

57

H Index

16

Total Docs (Last Year)

159

Total Docs (3 years)

927

Total Refs

270

Total Cites (3 years)

159

Citable Docs (3 years)

1.67

Cites/Doc (2 years)

57.94

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Swiss Medical Weekly Q3
Neurologia Q3
Canadian Journal of Experimental Psychology Q3
Journal of Physiology and Pharmacology Q3
Revista do Instituto de Medicina Tropical de Sao Paulo Q3

Compare this journals

Aims and Scope

Best articles by citations

Clinical experience with erlotinib in non-small-cell lung cancer (NSCLC)

Fever of unknown origin in HIV/AIDS patients

Temozolomide: Expanding its role in brain cancer

Therapeutic stimulation of penile nitric oxide synthase (NOS) and related pathways

Clinical studies of riluzole in amyotrophic lateral sclerosis

Pentostatin

Clinical studies with reteplase

Omoconazole nitrate

Albiglutide for the treatment of type 2 diabetes mellitus

Dorzolamide hydrochloride: A topically active, carbonic anhydrase inhibitor for the treatment of glaucoma

Calcium as a treatment of osteoporosis

Dual versus triple antithrombotic therapy: is there a role for direct oral anticoagulants in arterial thrombosis?

SHOW MORE ARTICLES

Physiological roles and properties of potassium channels in corporal smooth muscle

Eptifibatide: A cyclic peptide that selectively inhibits platelet glycoprotein IIb/IIIa

Retapamulin: A new topical antibiotic for the treatment of uncomplicated skin infections

Current perspectives of immunotherapy for colorectal cancer

Tesaglitazar: A promising approach in type 2 diabetes

Rofecoxib: A specific cyclooxygenase inhibitor

Roflumilast for COPD

Pneumococcal vaccines

Nitrergic-noradrenergic interaction in penile erection: A new insight into erectile dysfunction

Voriconazole: A second-generation triazole

Pancrelipase for pancreatic disorders: An update

Clopidogrel: A selective inhibitor of platelet ADP receptors